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Abstract 
The Child Neurology Society collaborated with the Pediatric Epilepsy Research Consortium to 
issue an online statement April 6, 2020 of immediate recommendations to streamline 
diagnosis, treatment, and follow up of infantile spasms. The recommendations encourage use 
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of telemedicine, outpatient over inpatient studies, and oral therapies as initial treatment. Each 
recommendation is earmarked as enduring if intended to outlast the pandemic, and limited if 
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“Crisis standards of care” are guidelines to help healthcare providers deliver the best 
possible medical care when resources are acutely limited, such as by war, natural 
disaster, or public health catastrophe. Public health officials and emergency 
preparedness experts have devoted significant professional effort to conceptualize and 
draft such guidelines,1 but there has been little attention to such planning in child 
neurology. As the current COVID-19 pandemic profoundly changed health care delivery, 
we felt growing uncertainty on how to approach one of the most important clinical 
scenarios in our practice: new onset infantile spasms.  
 
Infantile spasms occur typically in the first year of life once per 2400–5500 live births. 
This is roughly as often as other well-known pediatric disorders like cystic fibrosis, 
Tetralogy of Fallot, and type 1 diabetes. Infantile spasms cause a developmental 
epileptic encephalopathy – i.e., the abnormal cerebral electrical activity impairs 
cognition and derails ongoing developmental processes. Timely effective treatment 
improves the chance of resolution of epileptic spasms and improves outcomes. Thus 
rapid diagnosis is critical. Outcomes vary from normal to substantial 
neurodevelopmental disability, and depend both on treatment response, as well as the 
infant’s neurologic status prior to diagnosis (i.e., pre-existing risk of developmental 
impairment, pre-existing epilepsy at diagnosis, and etiology).2  
 
The COVID-19 pandemic has strained healthcare delivery, and mandated a change to 
standard management of infantile spasms. Traditionally, care involves an urgent 
inpatient evaluation to coordinate video-EEG monitoring, imaging, laboratory studies, 
and initiation of treatment. However, at present, every in-person healthcare visit puts 
children, their caregivers, and their clinicians at risk for infection, particularly given days-
long pre-symptomatic COVID-19 carriage3 and airborne transmission.4  
 
As we write, COVID-19 infections are common among patients admitted to hospitals, 
and many pediatric wards are occupied by sick adults. Governments worldwide have 
closed businesses and public spaces and issued stay-at-home orders to reduce 
community transmission. Although COVID-19 infections are milder in children, infants 
and immunocompromised individuals have the most severe disease among pediatric 
populations.5  
 
To balance clinical and public health imperatives, and to respond to urgent questions 
regarding patient management, the Child Neurology Society collaborated with the 
Pediatric Epilepsy Research Consortium to issue an online statement April 6, 2020 of 
immediate recommendations to streamline diagnosis, treatment, and follow up of 
infantile spasms.6 The recommendations encourage use of telemedicine, outpatient 
over inpatient studies, and oral therapies as initial treatment. Each recommendation is 
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earmarked as enduring if intended to outlast the pandemic, and limited if intended only 
during the duration of the pandemic.  
 
The statement included these enduring recommendations: 
  The initial clinical visit for suspected infantile spasms may be performed 
by telemedicine or video conference.   
  Parents should be instructed to obtain and share video of several 
consecutive typical events, to be reviewed prior to or during the initial clinical encounter. 
  The evaluation should include inquiry and observation for light spots on 
the skin, given the common association of infantile spasms with tuberous sclerosis 
complex (TSC). 
  EEG confirmation is strongly encouraged and should include at least one 
sleep-wake cycle, recognizing that epileptiform abnormalities are potentiated by sleep.  
  Hypsarrhythmia may be absent and is not required for the diagnosis.7  
  Following diagnosis, if the etiology is uncertain, an MRI is recommended 
urgently, for example to diagnose TSC or a structural brain lesion.8 A genetic evaluation 
can be high yield, and should also be prioritized. 
  For initial treatment, unless there are contraindications, select from among 
three choices: ACTH, high dose prednisolone (4-8 mg/kg/day), and vigabatrin.9 
  For TSC, vigabatrin is preferred if immediately available. Otherwise oral 
prednisolone should be initiated and an echocardiogram obtained. (Hormonal 
treatments can increase the size of cardiac rhabdomyomas.)   
  Non-standard therapies should be avoided as the first treatment choice for 
infantile spasms (e.g., topiramate, ketogenic diet, benzodiazepines).  
  For hormonal treatments, GI prophylaxis with a proton pump inhibitor or 
H2 blocker is recommended with steroid treatment, and a single prescription should 
include both two weeks at a high dose and a two-week taper.   
 
The statement included these limited recommendations: 
  Outpatient EEG is preferred over inpatient admission. The need for 
inpatient care is driven by the need for rapid and coordinated care, rather than by risk of 
cardiorespiratory instability or acute neurological decompensation. 
  Initiate treatment with high dose oral prednisolone in the outpatient setting, 
other than for TSC.  Prednisolone is inexpensive, readily available in commercial 
pharmacies, and orally administered, in contrast with ACTH and vigabatrin, which 
require use of subspecialty pharmacies, pre-approval by insurance, and special training 
of caregivers (ACTH, injections; vigabatrin, mixing of sachets). High-dose prednisolone 
regimens (4-8mg/kg/day) have better response rates than low dose prednisolone,10 
though the optimal regimen is not established.   
  Follow up via telehealth at least weekly. 
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  If using hormonal therapy, arrange to measure blood pressure at least 
weekly.  
  Limit laboratory testing to specific indications or clinical concerns.   
  If clinical spasms continue after 7-10 days, add or modify treatment 
without confirmatory EEG.   
  If clinical spasms resolve, or if the caregiver is uncertain, repeat an EEG, 
including at least one sleep-wake cycle, with preference for outpatient EEG. 
 
These recommendations are our crisis standard of care for new onset infantile spasms. 
The exigency of the current public health crisis demands a fast, effective pivot in how 
we manage our most vulnerable patients, including a shift to an outpatient based 
protocol for both diagnosis and treatment.  Heightened concern relates to the utilization 
of high dose steroid therapy placing the patients at risk for an iatrogenic 
immunocompromised state.  Our recommendations have appeared to receive 
widespread acceptance among the child neurology community, functioning within the 
confines of a new reality, if temporary, of a drastic reduction in availability of hospital-
based services.  Further study will be needed to assess the impact of these sudden 
changes.  While enduring recommendations are applicable throughout the pandemic 
and beyond, limited recommendations are intended for implementation during the time 
of the pandemic but may be needed for future crises of contagion.   
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